Home » Stock Quotes » STO:ATORX

Alligator Bioscience AB STO:ATORX

Today's live share price, quote history, chart & news

6.17 SEK
+0.07 (1.15%)
Price open 6.18
Previous close 6.10
Market cap 440.47M
Volume 46.96K
Day high 6.24
Day low 6.10
Year high 26.85
Year low 4.63

About Alligator Bioscience AB

Alligator Bioscience AB (publ) develops antibody-based pharmaceuticals for cancer treatment. It develops products using its technology platforms, including ALLIGATOR-GOLD, a proprietary human antibody library that contains approximately 60 billion unique antibody fragments; FIND, a molecular evolution technology for optimization of antibodies and other proteins; and bispecific fusion format for the development of novel dual-action antibodies. The company develops ADC-1013, an immunostimulatory antibody, which is in Phase I clinical trial for the treatment of metastatic cancer; and ATOR-1015, a tumor-localizing bispecific CTLA-4 and OX40 antibody, which is in Phase I clinical trial for tumor-directed treatment of metastatic cancer. Its drug candidates in preclinical development stage include ATOR-1017, an immunostimulatory antibody that binds to the costimulatory receptor 4-1BB (CD137) in tumor-specific T cells; ALG.APV-527, a bispecific 4-1BB and 5T4 antibody for the treatment of metastatic cancer; and ATOR-1144, a bispecific antibody for treating solid tumors and hematologic malignancies. The company, through its subsidiary, Atlas Therapeutics AB, also holds a stake in Biosynergy (AC101), a preclinical project. It has operations in the United States, Sweden, Asia, and internationally. The company has a partnership agreement with Aptevo Therapeutics Inc. for the co-development of ALG.APV-527; and a license agreement with Janssen Biotech, Inc. for developing ADC-1013. Alligator Bioscience AB (publ) was founded in 2001 and is headquartered in Lund, Sweden.

Name Alligator Bioscience AB
Exchange Stockholm Stock Exchange
Sector Healthcare
Industry Biotechnology
Country Sweden
Full time employees 55

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.